Related references
Note: Only part of the references are listed.Aripiprazole Augmentation in Major Depressive Disorder: A Double-Blind, Placebo-Controlled Study in Patients with Inadequate Response to Antidepressants
Robert M. Berman et al.
CNS SPECTRUMS (2009)
Daily and spaced treatment with transcranial magnetic stimulation in major depression: a pilot study
Yvonne Turnier-Shea et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2006)
Modafinil augmentation of SSRI therapy in patients with major depressive disorder and excessive sleepiness and fatigue: A 12-week, open-label, extension study
ME Thase et al.
CNS SPECTRUMS (2006)
Beyond monoamines: Glutamatergic function in mood disorders
A Kugaya et al.
CNS SPECTRUMS (2005)
Long-term outcome of neurosurgery for the treatment of resistant depression
PS Sachdev et al.
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES (2005)
Therapeutic alternatives for difficult-to-treat depression: A narrative review of the state of the evidence
ME Thase
CNS SPECTRUMS (2004)
Influence of dissolution media composition on drug release and in-vitro/in-vivo correlation for paracetamol matrix tablets prepared with novel carbomer polymers
J Parojcic et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2004)
Hopelessness and suicidal ideation in outpatients with treatment-resistant depression: Prevalence and impact on treatment outcome
GI Papakostas et al.
JOURNAL OF NERVOUS AND MENTAL DISEASE (2003)
The influence of cognitive reserve on memory following electroconvulsive therapy
SA Legendre et al.
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES (2003)
Efficacy of quetiapine and risperidone against depressive symptoms in outpatients with psychosis
M Sajatovic et al.
JOURNAL OF CLINICAL PSYCHIATRY (2002)
Identification of a claims data signature and economic consequences for treatment-resistant depression
PK Corey-Lisle et al.
JOURNAL OF CLINICAL PSYCHIATRY (2002)
Combining bupropion SR with venlafaxine, paroxetine, or fluoxetine: A preliminary report on pharmacokinetic, therapeutic, and sexual dysfunction effects
SH Kennedy et al.
JOURNAL OF CLINICAL PSYCHIATRY (2002)
Citalopram treatment of fluoxetine nonresponders
ME Thase et al.
JOURNAL OF CLINICAL PSYCHIATRY (2001)
Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors:: Results from a placebo-controlled, randomized, double-blind, placebo wash-in study
BG Appelberg et al.
JOURNAL OF CLINICAL PSYCHIATRY (2001)
Efficacy and safety of mirtazapine in major depressive disorder patients after SSRI treatment failure: An open-label trial
M Fava et al.
JOURNAL OF CLINICAL PSYCHIATRY (2001)
Partial response, nonresponse, and relapse with selective serotonin reuptake inhibitors in major depression: A survey of current next-step practices
SJ Fredman et al.
JOURNAL OF CLINICAL PSYCHIATRY (2000)
Modafinil augmentation of antidepressant treatment in depression
MA Menza et al.
JOURNAL OF CLINICAL PSYCHIATRY (2000)
Share Paper
